Oscar Health, Inc. $OSCR Shares Sold by Algert Global LLC

Key Points

• Algert Global LLC has significantly reduced its stake in Oscar Health, Inc. by 55.4%, selling 97,604 shares and now holding 78,692 shares valued at approximately $1,032,000.
• Several institutional investors, including Tempus Wealth Planning LLC and CWM LLC, have increased their positions in Oscar Health during the first quarter, indicating ongoing interest from the investment community.
• Analysts have notably lowered their ratings on Oscar Health, with the consensus price target now set at $12.07, reflecting a market perception of challenges facing the company.

Algert Global LLC decreased its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 55.4% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 78,692 shares of the company's stock after selling 97,604 shares during the quarter. Algert Global LLC's holdings in Oscar Health were worth $1,032,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Southeastern Asset Management Inc. TN grew its holdings in shares of Oscar Health by 52.2% during the fourth quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company's stock worth $42,082,000 after buying an additional 1,073,359 shares in the last quarter. Jacobs Levy Equity Management Inc. grew its holdings in shares of Oscar Health by 37.8% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 1,741,306 shares of the company's stock worth $23,403,000 after buying an additional 477,634 shares in the last quarter. Man Group plc grew its holdings in shares of Oscar Health by 344.8% during the fourth quarter. Man Group plc now owns 1,813,216 shares of the company's stock worth $24,370,000 after buying an additional 1,405,554 shares in the last quarter. Victory Capital Management Inc. grew its holdings in shares of Oscar Health by 23.8% during the first quarter. Victory Capital Management Inc. now owns 285,997 shares of the company's stock worth $3,749,000 after buying an additional 54,938 shares in the last quarter. Finally, Toronto Dominion Bank purchased a new stake in shares of Oscar Health during the fourth quarter worth $1,008,000. Hedge funds and other institutional investors own 75.70% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on OSCR shares. Raymond James Financial cut shares of Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Piper Sandler lowered their price target on shares of Oscar Health from $14.00 to $13.00 and set a "neutral" rating on the stock in a research report on Thursday, August 14th. Barclays lowered their price target on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a research report on Wednesday, July 23rd. UBS Group reissued a "sell" rating and set a $11.00 price target (down previously from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Finally, Wall Street Zen cut shares of Oscar Health from a "hold" rating to a "sell" rating in a research report on Saturday, August 9th. Four analysts have rated the stock with a Hold rating and five have given a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Strong Sell" and a consensus target price of $12.07.

Oscar Health Trading Down 0.2%

OSCR stock traded down $0.04 during mid-day trading on Wednesday, hitting $17.05. 10,780,507 shares of the company were exchanged, compared to its average volume of 13,614,514. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $4.41 billion, a P/E ratio of -21.03 and a beta of 1.86. The business has a fifty day simple moving average of $16.18 and a 200-day simple moving average of $14.83. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, topping the consensus estimate of ($0.90) by $0.01. The company had revenue of $2.86 billion during the quarter, compared to analyst estimates of $2.88 billion. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. Oscar Health's revenue was up 29.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.20 earnings per share. On average, equities research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.